| E & R Health Care Inc | |
| 3955 Sw 137th Avenue Ste 5, Miami, Florida 33175 | |
| (305) 468-9544 | |
| Name | E & R Health Care Inc |
|---|---|
| Location | 3955 Sw 137th Avenue Ste 5, Miami, Florida |
| Certified By | Medicare |
| Services Offered | Nursing Care Physical Therapy Occupational Therapy Medical Social Services Home Health Aide |
| Medicare ID | 103146 |
| Ownership Type | Proprietary |
| Service Area Zip Codes | 33010, 33012, 33013, 33014, 33015, 33016, 33018, 33026, 33030, 33033, 33034, 33056, 33125, 33126, 33128, 33130, 33134, 33135, 33142, 33144, 33145, 33150, 33155, 33157, 33161, 33165, 33166, 33172, 33173, 33174, 33175, 33176, 33177, 33178, 33183, 33184, 33186, 33187, 33193 |
| NPI Number | 1235401357 |
| Organization Name | E & R HEALTH CARE INC |
| Address | 3955 Sw 137th Ave, Suite 5, Miami, FL 33175 |
| Phone Number | 305-468-9544 |
News Archive
VitalHealth (MGMA Booth #1560) and Mayo Medical Laboratories have entered into a collaboration to offer VitalHealth's Electronic Health Record (EHR) product, including a solution for physician office connectivity, as part of Mayo Medical Laboratories' outreach offering.
Even for elderly people with no signs of dementia, those with hardening of the arteries are more likely to also have the beta-amyloid plaques in the brain that are a hallmark of Alzheimer's disease, according to a study published in the October 16, 2013, online issue of Neurology®, the medical journal of the American Academy of Neurology.
Dr. Christopher Basler, a professor in the Institute for Biomedical Sciences at Georgia State University, director of the university's Center for Microbial Pathogenesis and a Georgia Research Alliance Eminent Scholar in Microbial Pathogenesis, has received a two-year, $419,100 federal grant to study a virus similar to Ebola virus that causes disease in animals but not in humans.
Researchers from Intermountain Healthcare and University of Utah Health in Salt Lake City have launched two vital clinical trials to test the effectiveness and safety of two drugs -hydroxychloroquine (HCQ) and azithromycin - to treat patients with COVID-19 (infection with the novel coronavirus).
When published results are systematically tracked for drug trials registered with ClinicalTrials.gov, those from industry-funded trials are the likeliest to be favorable to the drug in question, report researchers at Children's Hospital Boston. Publishing in the August 3 issue of the Annals of Internal Medicine, the researchers call for more public disclosure about clinical drug trials at their outset to reduce the possibility of bias in the findings.
› Verified 3 days ago
| Quality Rating: |
News Archive
VitalHealth (MGMA Booth #1560) and Mayo Medical Laboratories have entered into a collaboration to offer VitalHealth's Electronic Health Record (EHR) product, including a solution for physician office connectivity, as part of Mayo Medical Laboratories' outreach offering.
Even for elderly people with no signs of dementia, those with hardening of the arteries are more likely to also have the beta-amyloid plaques in the brain that are a hallmark of Alzheimer's disease, according to a study published in the October 16, 2013, online issue of Neurology®, the medical journal of the American Academy of Neurology.
Dr. Christopher Basler, a professor in the Institute for Biomedical Sciences at Georgia State University, director of the university's Center for Microbial Pathogenesis and a Georgia Research Alliance Eminent Scholar in Microbial Pathogenesis, has received a two-year, $419,100 federal grant to study a virus similar to Ebola virus that causes disease in animals but not in humans.
Researchers from Intermountain Healthcare and University of Utah Health in Salt Lake City have launched two vital clinical trials to test the effectiveness and safety of two drugs -hydroxychloroquine (HCQ) and azithromycin - to treat patients with COVID-19 (infection with the novel coronavirus).
When published results are systematically tracked for drug trials registered with ClinicalTrials.gov, those from industry-funded trials are the likeliest to be favorable to the drug in question, report researchers at Children's Hospital Boston. Publishing in the August 3 issue of the Annals of Internal Medicine, the researchers call for more public disclosure about clinical drug trials at their outset to reduce the possibility of bias in the findings.
› Verified 3 days ago
| Quality Measure | Provider | National Avg. |
|---|---|---|
| How often the home health team began their patients’ care in a timely manner | 100 | 95.7 |
| How often the home health team taught patients (or their family caregivers) about their drugs | 96.6 | 98.6 |
| How often the home health team checked patients’ risk of falling | 100 | 99.6 |
| How often the home health team checked patients for depression | 100 | 97.4 |
| How often the home health team made sure that their patients have received a flu shot for the current flu season. | 55.3 | 78.7 |
| How often the home health team made sure that their patients have received a pneumococcal vaccine (pneumonia shot). | 55.1 | 82.2 |
| With diabetes, how often the home health team got doctor’s orders, gave foot care, and taught patients about foot care | 100 | 96.4 |
News Archive
VitalHealth (MGMA Booth #1560) and Mayo Medical Laboratories have entered into a collaboration to offer VitalHealth's Electronic Health Record (EHR) product, including a solution for physician office connectivity, as part of Mayo Medical Laboratories' outreach offering.
Even for elderly people with no signs of dementia, those with hardening of the arteries are more likely to also have the beta-amyloid plaques in the brain that are a hallmark of Alzheimer's disease, according to a study published in the October 16, 2013, online issue of Neurology®, the medical journal of the American Academy of Neurology.
Dr. Christopher Basler, a professor in the Institute for Biomedical Sciences at Georgia State University, director of the university's Center for Microbial Pathogenesis and a Georgia Research Alliance Eminent Scholar in Microbial Pathogenesis, has received a two-year, $419,100 federal grant to study a virus similar to Ebola virus that causes disease in animals but not in humans.
Researchers from Intermountain Healthcare and University of Utah Health in Salt Lake City have launched two vital clinical trials to test the effectiveness and safety of two drugs -hydroxychloroquine (HCQ) and azithromycin - to treat patients with COVID-19 (infection with the novel coronavirus).
When published results are systematically tracked for drug trials registered with ClinicalTrials.gov, those from industry-funded trials are the likeliest to be favorable to the drug in question, report researchers at Children's Hospital Boston. Publishing in the August 3 issue of the Annals of Internal Medicine, the researchers call for more public disclosure about clinical drug trials at their outset to reduce the possibility of bias in the findings.
› Verified 3 days ago
| Quality Measure | Provider | National Avg. |
|---|---|---|
| How often patients got better at walking or moving around | 82.2 | 79.6 |
| How often patients got better at getting in and out of bed | 83.2 | 81.1 |
| How often patients got better at bathing | 82 | 82.3 |
| How often patients’ breathing improved | 22.2 | 82.8 |
| How often patients’ wounds improved or healed after an operation | - | 92.3 |
| How often patients got better at taking their drugs correctly by mouth | 21.2 | 75 |
| How often home health patients had to be admitted to the hospital | 12.1 | 15.4 |
| How often patients receiving home health care needed urgent, unplanned care in the ER without being admitted | 4.9 | 13 |
| How often physician-recommended actions to address medication issues were completely timely | 74.3 | 94 |
News Archive
VitalHealth (MGMA Booth #1560) and Mayo Medical Laboratories have entered into a collaboration to offer VitalHealth's Electronic Health Record (EHR) product, including a solution for physician office connectivity, as part of Mayo Medical Laboratories' outreach offering.
Even for elderly people with no signs of dementia, those with hardening of the arteries are more likely to also have the beta-amyloid plaques in the brain that are a hallmark of Alzheimer's disease, according to a study published in the October 16, 2013, online issue of Neurology®, the medical journal of the American Academy of Neurology.
Dr. Christopher Basler, a professor in the Institute for Biomedical Sciences at Georgia State University, director of the university's Center for Microbial Pathogenesis and a Georgia Research Alliance Eminent Scholar in Microbial Pathogenesis, has received a two-year, $419,100 federal grant to study a virus similar to Ebola virus that causes disease in animals but not in humans.
Researchers from Intermountain Healthcare and University of Utah Health in Salt Lake City have launched two vital clinical trials to test the effectiveness and safety of two drugs -hydroxychloroquine (HCQ) and azithromycin - to treat patients with COVID-19 (infection with the novel coronavirus).
When published results are systematically tracked for drug trials registered with ClinicalTrials.gov, those from industry-funded trials are the likeliest to be favorable to the drug in question, report researchers at Children's Hospital Boston. Publishing in the August 3 issue of the Annals of Internal Medicine, the researchers call for more public disclosure about clinical drug trials at their outset to reduce the possibility of bias in the findings.
› Verified 3 days ago
| Question Type: | Rating by Patients |
|---|---|
| Health team gave care in a professional way | Not Available |
| Health team communicated well with them | Not Available |
| Health team discussed medicines, pain, and home safety | Not Available |
| How patients rated overall care from agency | Not Available |
News Archive
VitalHealth (MGMA Booth #1560) and Mayo Medical Laboratories have entered into a collaboration to offer VitalHealth's Electronic Health Record (EHR) product, including a solution for physician office connectivity, as part of Mayo Medical Laboratories' outreach offering.
Even for elderly people with no signs of dementia, those with hardening of the arteries are more likely to also have the beta-amyloid plaques in the brain that are a hallmark of Alzheimer's disease, according to a study published in the October 16, 2013, online issue of Neurology®, the medical journal of the American Academy of Neurology.
Dr. Christopher Basler, a professor in the Institute for Biomedical Sciences at Georgia State University, director of the university's Center for Microbial Pathogenesis and a Georgia Research Alliance Eminent Scholar in Microbial Pathogenesis, has received a two-year, $419,100 federal grant to study a virus similar to Ebola virus that causes disease in animals but not in humans.
Researchers from Intermountain Healthcare and University of Utah Health in Salt Lake City have launched two vital clinical trials to test the effectiveness and safety of two drugs -hydroxychloroquine (HCQ) and azithromycin - to treat patients with COVID-19 (infection with the novel coronavirus).
When published results are systematically tracked for drug trials registered with ClinicalTrials.gov, those from industry-funded trials are the likeliest to be favorable to the drug in question, report researchers at Children's Hospital Boston. Publishing in the August 3 issue of the Annals of Internal Medicine, the researchers call for more public disclosure about clinical drug trials at their outset to reduce the possibility of bias in the findings.
› Verified 3 days ago
The patient survey data of E & R Health Care Inc is compared against the national average with the color code indicators: Better than National Average Worse than National Average| Experience Measure | Provider | National Avg. |
|---|---|---|
| Percent of patients who reported that their home health team gave care in a professional way | 100 | 88 |
| Percent of patients who reported that their home health team communicated well with them | 94 | 85 |
| Percent of patients who reported that their home health team discussed medicines, pain, and home safety with them | 93 | 83 |
| Percent of patients who gave their home health agency a rating of 9 or 10 on a scale from 0 (lowest) to 10 (highest) | 94 | 84 |
| Percent of patients who reported YES, they would definitely recommend the home health agency to friends and family | 94 | 78 |
News Archive
VitalHealth (MGMA Booth #1560) and Mayo Medical Laboratories have entered into a collaboration to offer VitalHealth's Electronic Health Record (EHR) product, including a solution for physician office connectivity, as part of Mayo Medical Laboratories' outreach offering.
Even for elderly people with no signs of dementia, those with hardening of the arteries are more likely to also have the beta-amyloid plaques in the brain that are a hallmark of Alzheimer's disease, according to a study published in the October 16, 2013, online issue of Neurology®, the medical journal of the American Academy of Neurology.
Dr. Christopher Basler, a professor in the Institute for Biomedical Sciences at Georgia State University, director of the university's Center for Microbial Pathogenesis and a Georgia Research Alliance Eminent Scholar in Microbial Pathogenesis, has received a two-year, $419,100 federal grant to study a virus similar to Ebola virus that causes disease in animals but not in humans.
Researchers from Intermountain Healthcare and University of Utah Health in Salt Lake City have launched two vital clinical trials to test the effectiveness and safety of two drugs -hydroxychloroquine (HCQ) and azithromycin - to treat patients with COVID-19 (infection with the novel coronavirus).
When published results are systematically tracked for drug trials registered with ClinicalTrials.gov, those from industry-funded trials are the likeliest to be favorable to the drug in question, report researchers at Children's Hospital Boston. Publishing in the August 3 issue of the Annals of Internal Medicine, the researchers call for more public disclosure about clinical drug trials at their outset to reduce the possibility of bias in the findings.
› Verified 3 days ago
New Sky Home Health Care Corp Location: 7235 Sw 24 St Ste 204, Miami, Florida 33155 Ratings: NA Phone: (305) 558-6454 | |
E & R Health Care Inc Location: 3955 Sw 137th Avenue Ste 5, Miami, Florida 33175 Ratings: Phone: (305) 468-9544 | |
Cruz Healthcare Corp Location: 10300 Sunset Drive Ste 444, Miami, Florida 33173 Ratings: Phone: (305) 221-9981 | |
Alleanza Health Care Associates Llc Location: 15190 Sw 136th Street Suite 32, Miami, Florida 33196 Ratings: Phone: (305) 238-1441 | |
American Providers, Inc. Location: 2000 Nw 89th Pl, Miami, Florida 33172 Ratings: Phone: (305) 591-9975 | |
Baptist Health Home Care Location: 12400 Sw 127 Ave, Miami, Florida 33186 Ratings: Phone: (786) 596-3010 |